Literature DB >> 28634185

Low-Dose Aspirin and Pancreatic Cancer Risk-Reply.

Harvey A Risch1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28634185      PMCID： PMC5500422          DOI： 10.1158/1055-9965.EPI-17-0208

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN： 1055-9965            Impact factor:   4.254


× No keyword cloud information.
  5 in total

1.  Low-Dose Aspirin and Pancreatic Cancer Risk-Letter.

Authors:  Theodore M Brasky; Jean Wactawski-Wende
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-20       Impact factor: 4.254

2.  Nonsteroidal anti-inflammatory drugs, statins, and pancreatic cancer risk: a population-based case-control study.

Authors:  Pik Fang Kho; Jonathan Fawcett; Lin Fritschi; Harvey Risch; Penelope M Webb; David C Whiteman; Rachel E Neale
Journal:  Cancer Causes Control       Date:  2016-11-05       Impact factor: 2.506

3.  Aspirin therapy reduces the ability of platelets to promote colon and pancreatic cancer cell proliferation: Implications for the oncoprotein c-MYC.

Authors:  Annachiara Mitrugno; Joanna L Sylman; Anh T P Ngo; Jiaqing Pang; Rosalie C Sears; Craig D Williams; Owen J T McCarty
Journal:  Am J Physiol Cell Physiol       Date:  2016-11-30       Impact factor: 4.249

4.  Aspirin Use and Reduced Risk of Pancreatic Cancer.

Authors:  Harvey A Risch; Lingeng Lu; Samantha A Streicher; Jing Wang; Wei Zhang; Quanxing Ni; Mark S Kidd; Herbert Yu; Yu-Tang Gao
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2016-12-20       Impact factor: 4.254

5.  Effect of low-dose aspirin use on pancreatic cancer development and morphological changes on imaging in IPMN: A long-term cohort study.

Authors:  Yusuke Takasaki; Naoyoshi Nagata; Koh Imbe; Yuya Hisada; Katsunori Sekine; Tsuyoshi Tajima; Mikio Yanase; Kazuma Fujimoto; Junichi Akiyama; Naomi Uemura
Journal:  United European Gastroenterol J       Date:  2017-02-05       Impact factor: 4.623
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.